Tillman Hartley LLC’s Pfizer PFE Stock Holding History

Tillman Hartley LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,781	Closed	-$218K	–	79
2024 Q2	$218K	Hold	7,781	–	–	0.07%	74
2024 Q1	$216K	Hold	7,781	–	–	0.07%	79
2023 Q4	$224K	Hold	7,781	–	–	0.08%	72
2023 Q3	$258K	Hold	7,781	–	–	0.11%	65
2023 Q2	$285K	Hold	7,781	–	–	0.11%	64
2023 Q1	$317K	Hold	7,781	–	–	0.13%	55
2022 Q4	$399K	Buy	+7,781	New	+$373K	0.17%	50

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Tillman Hartley LLC's PFE Position: Q3 2024 in Review

Tillman Hartley LLC sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,781 shares — an estimated $218K sold.

Tillman Hartley LLC first reported a position in PFE in Q4 2022 and held it in 7 quarters. The position peaked at $399K in Q4 2022. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Tillman Hartley LLC reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Tillman Hartley LLC sold 7,781 Pfizer shares in Q3 2024, an estimated $218K.
Tillman Hartley LLC first reported a position in Pfizer in Q4 2022 and held it in 7 quarters.
Tillman Hartley LLC's Pfizer position peaked at $399K in Q4 2022.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Tillman Hartley LLC's 13F filing for Q3 2024, filed 1 Nov 2024.